Literature DB >> 19096948

Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark.

Jeanne Debess1, Jens Østergaard Riis, Lars Pedersen, Marianne Ewertz.   

Abstract

OBJECTIVE: The aim of this study was to assess cognitive function, quality of life, and psychological distress after surgery for early breast cancer but before initiation of adjuvant treatment.
MATERIAL AND METHODS: We performed a population-based study in the county of North Jutland, Denmark, including 124 women aged less than 60 years who had surgery for early breast cancer from 2004 - 2006. They were compared with an aged-matched group of 224 women without previous cancer selected randomly from the same population. The cognitive function of patients and controls was tested using a revised battery from the ISPOCD study. Data were collected on quality of life (EORTC QLQ-C30) and psychological distress (POMS). RESULT: The neuropsychological tests did not reveal significant differences between patients and controls. Compared to the control group, breast cancer patients had a significantly 3 - 4 fold increased risk of experiencing cognitive impairment. Quality of life and psychological distress were also significantly poorer among patients.
CONCLUSION: This study demonstrated that women diagnosed with breast cancer experience a significant deterioration of their perceived cognitive functioning, quality of life and of psychological well being.

Entities:  

Mesh:

Year:  2009        PMID: 19096948     DOI: 10.1080/02841860802600755

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  18 in total

1.  Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study.

Authors:  Jin-Hee Park; Yong Sik Jung; Ku Sang Kim; Sun Hyoung Bae
Journal:  Support Care Cancer       Date:  2017-01-28       Impact factor: 3.603

2.  Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors.

Authors:  Yuan-Yuan Lei; Suzanne C Ho; Thomas K H Lau; Carol Kwok; Ashley Cheng; Ka Li Cheung; Roselle Lee; Winnie Yeo
Journal:  Qual Life Res       Date:  2021-01-14       Impact factor: 4.147

3.  Self-efficacy, adjustment style and well-being in breast cancer patients: a longitudinal study.

Authors:  Nina Rottmann; Susanne O Dalton; Jane Christensen; Kirsten Frederiksen; Christoffer Johansen
Journal:  Qual Life Res       Date:  2010-04-17       Impact factor: 4.147

Review 4.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

5.  Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review.

Authors:  Alain Monnier
Journal:  Ther Clin Risk Manag       Date:  2009-09-15       Impact factor: 2.423

6.  Social and psychological determinants of participation in internet-based cancer support groups.

Authors:  Mette Terp Høybye; Susanne Oksbjerg Dalton; Jane Christensen; Lone Ross; Katrin Gaardbo Kuhn; Christoffer Johansen
Journal:  Support Care Cancer       Date:  2009-07-05       Impact factor: 3.603

7.  Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.

Authors:  Christine Rotonda; Francis Guillemin; Franck Bonnetain; Michel Velten; Thierry Conroy
Journal:  Oncologist       Date:  2013-02-12

8.  Well-being of newly diagnosed women with breast cancer: which factors matter more?

Authors:  Rugilė Ivanauskienė; Žilvinas Padaiga; Renata Šimoliūnienė; Giedrė Smailytė; Auksė Domeikienė
Journal:  Support Care Cancer       Date:  2013-10-18       Impact factor: 3.603

Review 9.  Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Simone Perna; Neldo Antoniello
Journal:  Aging Clin Exp Res       Date:  2013-09-18       Impact factor: 3.636

10.  The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.

Authors:  Melissa Voigt Hansen; Michael Tvilling Madsen; Ida Hageman; Lars Simon Rasmussen; Susanne Bokmand; Jacob Rosenberg; Ismail Gögenur
Journal:  BMJ Open       Date:  2012-01-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.